Skip to content
Inciteful Med

Recognizing the Symptoms of Sjögren-Larsson Syndrome

Last updated:

Sjögren-Larsson Syndrome (SLS) is a rare condition defined by a classic triad of symptoms: dry and scaly skin (ichthyosis), muscle stiffness (spasticity), and intellectual disability. Symptoms usually appear in the first few years of life, starting with severe skin changes at birth.

Key Takeaways

  • • Ichthyosis, or severe skin scaling, is usually the very first sign of Sjögren-Larsson Syndrome and is often present at birth.
  • • Neurological symptoms like muscle stiffness (spasticity) typically emerge between 6 months and 2 years of age.
  • • Children with SLS often develop unique eye symptoms, including extreme light sensitivity and glistening white dots in the retina.
  • • Severe, difficult-to-treat itching (intractable pruritus) is a common but frequently overlooked symptom that can severely disrupt a child's sleep.
  • • While symptoms vary in severity even among siblings, early intervention with physical therapy is critical to manage muscle stiffness as the child grows.

Understanding the symptoms of Sjögren-Larsson Syndrome (SLS) is a journey of connecting different signs that may at first seem unrelated. While the condition is defined by a “classic triad” of skin, movement, and learning symptoms, the way these appear can vary significantly from one child to another [1][2].

The Classic Triad

Most children with SLS will experience three primary symptoms, typically appearing in a predictable timeline:

1. Ichthyosis (Skin Scaling)

In almost all cases, ichthyosis—dry, thickened, and scaly skin—is the very first sign [3]. It is usually present at birth, sometimes appearing as a “collodion membrane”—a shiny, tight layer of skin that typically sheds shortly after birth [4][5]—or as generalized scaling. While it affects the whole body, it is often more visible on the trunk and in skin folds [3].

2. Spasticity (Muscle Stiffness)

Neurological symptoms, specifically spasticity (stiff, tight muscles), typically emerge within the first two years of life [6]. This most often affects the legs (spastic diplegia) but can involve the arms as well (spastic tetraplegia) [1]. While the condition is often considered “static” (meaning it doesn’t always get worse over time), the stiffness can lead to permanent muscle shortening (contractures) as a child grows [6][7].

3. Intellectual Disability

Most children experience developmental delays and some degree of intellectual disability, ranging from mild to moderate [8][9]. However, the severity varies; some rare cases of children with normal intelligence have been documented [10].

What to Expect: The First Five Years

While every child is different, a general timeline can help you prepare:

  • Birth to 6 Months: Skin symptoms (ichthyosis) are the primary focus. You may also notice early feeding difficulties or irritability linked to dry skin [11].
  • 6 Months to 2 Years: Neurological symptoms begin to emerge. You may notice your child missing motor milestones (like sitting or crawling) and displaying stiffness (spasticity) in their legs [6]. This is the critical time to push for early intervention physical therapy.
  • Ages 3 to 5: Cognitive delays often become more apparent as peers accelerate in language and complex play [12]. Mobility aids, such as walkers or wheelchairs, are often introduced during this window [1].

Overlooked and Hidden Symptoms

Beyond the classic triad, there are other symptoms that can be just as impactful but are sometimes overlooked:

  • Intractable Pruritus (Severe Itching): This is a nearly universal feature of SLS [13]. Unlike a normal itch, this is “intractable,” meaning it is very difficult to soothe and can severely disrupt a child’s sleep and quality of life [13][11].
  • Photophobia (Light Sensitivity): Many children find bright light uncomfortable [12]. This is likely linked to how the fatty substances buildup affects the retina in the eye [12].
  • Crystalline Maculopathy: A hallmark of SLS is the appearance of tiny, “glistening” yellow-white dots in the retina [12][14]. These inclusions are dynamic and can change in number over time [15].
  • Feeding and Swallowing Issues: About 75% of individuals with SLS experience some difficulty with swallowing (dysphagia) or feeding [11].

Why Misdiagnosis Happens

SLS is frequently confused with other conditions because its symptoms overlap with more common disorders:

Condition Overlap with SLS Key Differences in SLS
Cerebral Palsy (CP) Muscle stiffness and developmental delays [8]. SLS includes ichthyosis and unique eye crystals not found in CP [12][9].
Standalone Ichthyosis Scaly, dry skin from birth [16]. Standard ichthyosis does not involve neurological stiffness or intellectual disability [17].

A key way doctors tell the difference is through a brain MRI, which in SLS typically shows symmetrical “white matter hyperintensities”—a specific pattern of change in the brain’s insulation [18][19].

A Wide Range of Severity

It is important to remember that SLS is highly variable [1]. Even within the same family, siblings with the exact same genetic mutation can have very different levels of severity [20]. Some children may have very mild skin issues but more significant walking challenges, while others may have the opposite [6][1]. This means your child’s journey will be unique to them.

For a deeper understanding of how these symptoms are confirmed clinically, continue to The Biology and Diagnosis of Sjögren-Larsson Syndrome.

Frequently Asked Questions

What are the very first signs of Sjögren-Larsson Syndrome?
The earliest sign of Sjögren-Larsson Syndrome is typically ichthyosis, which is dry, thickened, and scaly skin. It is usually present at birth and often appears first as a tight, shiny layer of skin that sheds shortly after.
What is the classic triad of Sjögren-Larsson Syndrome?
The classic triad of symptoms includes severe skin scaling (ichthyosis), muscle stiffness (spasticity), and intellectual disability. These symptoms generally appear in a predictable timeline during a child's first few years of life.
How is Sjögren-Larsson Syndrome different from cerebral palsy?
While both conditions cause muscle stiffness and developmental delays, Sjögren-Larsson Syndrome also includes severe skin scaling and specific changes in the eyes, like crystalline maculopathy. A brain MRI can also help doctors spot unique white matter changes specific to SLS.
What eye problems are associated with Sjögren-Larsson Syndrome?
Children with this syndrome often develop crystalline maculopathy, which appears as tiny, glistening yellow-white dots in the retina. Many children also experience severe photophobia, making bright lights very uncomfortable for them.
Will my child's muscle stiffness from SLS get worse over time?
The neurological symptoms of SLS are often considered static, meaning the underlying nerve damage does not continually worsen. However, as a child grows, the muscle stiffness can lead to permanent muscle shortening or contractures without regular physical therapy.

Questions for Your Doctor

  • • Does my child have the 'glistening yellow dots' in their retina that are characteristic of SLS?
  • • How can we distinguish my child's muscle stiffness from common cerebral palsy?
  • • What are the latest options for managing 'intractable pruritus' if standard lotions aren't working?
  • • Since SLS can vary even among siblings, how can we best monitor the specific progression of my child's neurological symptoms?
  • • Should we perform a brain MRI or MRS to look for the symmetrical white matter changes often seen in SLS?

Questions for You

  • • When did the skin scaling first appear, and has it changed in location or severity over time?
  • • Did your child reach early motor milestones (like sitting or crawling) on time, or was there noticeable stiffness in their legs?
  • • How significantly is the itching affecting your child’s sleep and focus during the day?
  • • Are there other family members with similar skin or movement issues, even if they were never formally diagnosed with SLS?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Phenotypic and mutational spectrum of thirty-five patients with Sjögren-Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects.

    Abdel-Hamid MS, Issa MY, Elbendary HM, et al.

    Journal of human genetics 2019; (64(9)):859-865 doi:10.1038/s10038-019-0637-x.

    PMID: 31273323
  2. 2

    Genotype and phenotype variability in Sjögren-Larsson syndrome.

    Weustenfeld M, Eidelpes R, Schmuth M, et al.

    Human mutation 2019; (40(2)):177-186 doi:10.1002/humu.23679.

    PMID: 30372562
  3. 3

    Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.

    Amr K, El-Bassyouni HT, Ismail S, et al.

    Archives of dermatological research 2019; (311(9)):721-730 doi:10.1007/s00403-019-01953-6.

    PMID: 31388754
  4. 4

    Sjogren-Larsson Syndrome: A case series of five members from an extended family with a novel mutation.

    Abidi KT, Kamal NM, Bakkar A AA, et al.

    Molecular genetics & genomic medicine 2020; (8(11)):e1487 doi:10.1002/mgg3.1487.

    PMID: 32930514
  5. 5

    Clinical and molecular characterization and response to acitretin in three families with Sjögren-Larsson syndrome.

    Vural S, Vural A, Akçimen F, et al.

    International journal of dermatology 2018; (57(7)):843-848 doi:10.1111/ijd.14013.

    PMID: 29704247
  6. 6

    A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.

    Warrack S, Love T, Rizzo WB

    Journal of child neurology 2021; (36(11)):1011-1016 doi:10.1177/08830738211029390.

    PMID: 34315315
  7. 7

    Sjögren-Larsson Syndrome: A Rare Presentation With Developmental Delay.

    J SK, Waheed MD, Batool S, et al.

    Cureus 2023; (15(2)):e35159 doi:10.7759/cureus.35159.

    PMID: 36950004
  8. 8

    Sjögren-Larsson syndrome: Anesthetic considerations and practical recommendations.

    Franzen MH, LeRiger MM, Pellegrino KP, et al.

    Paediatric anaesthesia 2020; (30(12)):1390-1395 doi:10.1111/pan.14034.

    PMID: 33037729
  9. 9

    Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome.

    Cho KH, Shim SH, Kim M

    Clinical genetics 2018; (93(4)):721-730 doi:10.1111/cge.13058.

    PMID: 28543186
  10. 10

    Sjögren-Larsson syndrome: The mild end of the phenotypic spectrum.

    Staps P, van Gaalen J, van Domburg P, et al.

    JIMD reports 2020; (53(1)):61-70 doi:10.1002/jmd2.12099.

    PMID: 32395410
  11. 11

    Daily Functioning and Quality of Life in Patients with Sjögren-Larsson Syndrome.

    Staps P, de Groot IJM, van Gerven MHJC, Willemsen MAAP

    Neuropediatrics 2019; (50(2)):89-95 doi:10.1055/s-0038-1676854.

    PMID: 30609437
  12. 12

    Sjögren-Larsson syndrome: a complex metabolic disease with a distinctive ocular phenotype.

    Fouzdar-Jain S, Suh DW, Rizzo WB

    Ophthalmic genetics 2019; (40(4)):298-308 doi:10.1080/13816810.2019.1660379.

    PMID: 31512987
  13. 13

    Dupilumab Reduces Pruritus in Twins With Sjögren-Larsson Syndrome.

    Gallagher K, Yousif R, Hummel K, Paller AS

    Pediatric dermatology 2025; doi:10.1111/pde.70073.

    PMID: 41046861
  14. 14

    End-stage crystalline maculopathy with retinal atrophy in Sjögren-Larsson syndrome: a case report and review of the literature.

    Lambert LH, Shaikh N, Marx JL, Ramsey DJ

    Therapeutic advances in rare disease 2022; (3()):26330040221122496 doi:10.1177/26330040221122496.

    PMID: 37180414
  15. 15

    Macular crystalline inclusions in Sjögren-Larsson syndrome are dynamic structures that undergo remodeling.

    Al-Holou SN, Siefker E, Fouzdar-Jain S, et al.

    Ophthalmic genetics 2020; (41(4)):381-385 doi:10.1080/13816810.2020.1776340.

    PMID: 32506993
  16. 16

    Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome.

    Nojiri K, Fudetani S, Arai A, et al.

    Molecular and cellular biology 2021; (41(10)):e0035221 doi:10.1128/MCB.00352-21.

    PMID: 34370553
  17. 17

    Ceramide profiling of stratum corneum in Sjögren-Larsson syndrome.

    Arai A, Takeichi T, Wakamoto H, et al.

    Journal of dermatological science 2022; (107(3)):114-122 doi:10.1016/j.jdermsci.2022.08.003.

    PMID: 35973883
  18. 18

    Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.

    Roy U, Das U, Pandit A, Debnath A

    BMJ case reports 2016; (2016()):10.1136/bcr-2016-215110.

    PMID: 27095813
  19. 19

    Disturbed brain ether lipid metabolism and histology in Sjögren-Larsson syndrome.

    Staps P, Rizzo WB, Vaz FM, et al.

    Journal of inherited metabolic disease 2020; (43(6)):1265-1278 doi:10.1002/jimd.12275.

    PMID: 32557630
  20. 20

    Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran.

    Kariminejad A, Barzgar M, Bozorgmehr B, et al.

    European journal of medical genetics 2018; (61(3)):139-144 doi:10.1016/j.ejmg.2017.11.006.

    PMID: 29183715

This page is for informational purposes only and does not replace professional medical advice. Always consult your child's pediatrician or neurologist regarding symptom management and diagnosis.

Stay up to date

Get notified when new research about Sjögren-Larsson syndrome is published.

No spam. Unsubscribe anytime.